CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Innoventric is developing the Trillium, a minimally invasive transcatheter valve replacement for treating tricuspid regurgitation, a common heart condition. This innovative solution aims to provide a safer and quicker alternative to traditional open-heart surgery for patients with severe cases of the disorder.
Tricuspid regurgitation (TR) is a cardiac disorder in which the tricuspid valve leaks during systole causing blood backflow, resulting in decreased cardiac output. TR is the most common valvular heart disease affecting 65%-85% of the global population in its mild form.
However, mild TR can progress to severe TR, leading to heart failure or death if left untreated.
Today, the only option for treatment is valve repair or replacement through open-heart surgery, which is associated with high mortali…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
